Accreditation and Designation User Manual - OECI
Accreditation and Designation User Manual - OECI
Accreditation and Designation User Manual - OECI
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
3.2 Audit team <strong>and</strong> auditors<br />
3.2.1 <strong>OECI</strong> audit team<br />
This part gives explanations about the <strong>OECI</strong> audit team. More details about the tasks <strong>and</strong> responsibilities of<br />
individual auditors can be find in the part ‘<strong>OECI</strong> auditor’.<br />
Composition of the audit team<br />
The audit team typically consists of four members:<br />
− Chair, who is also one of the auditors,<br />
− Three auditors,<br />
− In case of a preliminary Cancer Unit the audit team possibly includes less than four auditors <strong>and</strong> the peer review<br />
possible takes one day,<br />
− In case of a preliminary CCC one person of the audit team possibly starts half a day earlier to check the<br />
designation criteria/checklist in advance.<br />
In an ideal situation the team consists of:<br />
− A chair who is a director of a cancer institute,<br />
− Auditors with different positions/ functions in different fields of oncology, like: medical oncology, care, research,<br />
pathology, quality assurance,<br />
− At least one auditor who underst<strong>and</strong>s the language of the country where the cancer institute is situated but who<br />
is not a resident of that country,<br />
− A mix of experienced <strong>and</strong> less experienced auditors.<br />
Besides the audit team the <strong>OECI</strong> <strong>Accreditation</strong> Coordinator will also be present during the peer review visit to<br />
coordinate the peer review activities.<br />
Selecting an audit team<br />
The Executive Manager <strong>and</strong> A&D Coordinator are responsible for selecting the chair <strong>and</strong> auditors of an audit<br />
team.<br />
Before the audit team members will get access to the self-assesment information of the cancer institute:<br />
− The particular cancer institute has expressed that there is no conflict of interest with any of the audit team<br />
members (4.1),<br />
− Each auditor has signed a Confidentiality Agreement (doc 14) <strong>and</strong> a Conflict of Interest Form (doc 15).<br />
3.2.2 <strong>OECI</strong> Audit team chair<br />
The chair of the audit team has the same profile, tasks <strong>and</strong> obligations as the <strong>OECI</strong> Auditor (3.2.3). However, the<br />
chair has some specific additional obligations <strong>and</strong> tasks.<br />
Profile<br />
− The chair is a Director of a cancer institute (or a position with comparable authority to be decided by the <strong>OECI</strong><br />
A&D Board),<br />
− The chair has attended the auditors’ training,<br />
− The chair has experienced at least one peer review as auditor before chairing a peer review.<br />
Tasks<br />
− The chair opens the peer review visit with a presentation,<br />
− The chair has a leading role in the representation of the team,<br />
− The chair has a leading role in a balanced division of tasks in the team,<br />
− The chair has a leading role in meetings <strong>and</strong> interviews,<br />
− The chair presents the preliminary results at the end of the peer review visit,<br />
− The chair presents the preliminary designation type at the end of the peer review visit,<br />
− The chair has a leading role in the content of the report <strong>and</strong> editorial changes.<br />
Owner: <strong>OECI</strong> Organisation of European Cancer Institutes<br />
Status: Revised - 24 th January 2011 - A&D Working Group<br />
Approved by: <strong>OECI</strong> <strong>Accreditation</strong> <strong>and</strong> <strong>Designation</strong> Board<br />
Chapter 3 People <strong>and</strong> parties involved in the A&D programme<br />
Page 6 of 8<br />
Version 16 February 2011